Having demonstrated that BAP18 acts as a co-activator of ERα to enhance estrogen-ERα mediated transactivation, we thus turn to examine the biological function of BAP18 in ERα-positive breast cancer cell lines, such as MCF7 cells and T47D cells. This evidence concerns the gene ESR1 and breast carcinoma.